A significant advance in cancer research is emerging with the use of mini-antibodies to reactivate dysfunctional p53. This essential tumor inhibitor protein is frequently inactivated in many forms of malignancies, https://cruxbookmarks.com/story22039457/nanobodies-revive-the-p53-protein-new-new-pathway-for-malignant-management